Justina Petrullo

Naveen Mansukhani, director of operations and account management of Retail Pharmacy Services at Cardinal Health, talks about how the responsibility for saving costs does not just fall on one department or person, but is collaborative and requires strategy.

David Spencer, MD, director of the Comprehensive Epilepsy Center and professor of neurology at Oregon Health and Science University, talks about the first-in-human trial of interneuron cell therapy for treatment of focal epilepsy and explains the next steps.

Technology and automation within patient assistance programs can enhance the patient journey and assist pharmaceutical manufacturers at a lower cost, explained Josh Marsh, vice president of Sonexus at Cardinal Health.

Milena Pavlova, MD, neurologist, and medical director of the sleep testing center at Brigham and Women’s Faulkner hospital, talks about the importance of treating underlying sleep disorders in patients with seizures, especially within a value-based care (VBC) model.

Type 2 diabetes drug tirzepatide (Mounjaro) helped some individuals lose nearly 16% of their body weight; some vital drugs have been sporadically in shortage for over 8 years; a bacterial outbreak of klebsiella claimed 4 lives and infected 31 people in a Seattle hospital.

David Spencer, MD, director of the Comprehensive Epilepsy Center and professor of neurology at Oregon Health and Science University, talks about how an emerging epilepsy treatment could transform the current level of care for patients with the condition.

Milena Pavlova, MD, neurologist and medical director of the sleep testing center at Brigham and Women’s Faulkner Hospital, discusses the profound effect obstructive sleep apnea has on epilepsy as well as cognition.

Shruti Agnihotri, MD, associate professor at the University of Alabama Birmingham, discusses how value-based care can help patients who experience neurologic chronic disease states after COVID-19, in addition to patients with conditions like stroke and dementia.

Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist, talks about how data on the LGBTQ+ community in the neurology space is needed in order to provide effective value-based health care.

Jessica Robinson-Papp, MD, MS, professor of neurology at Icahn School of Medicine at Mount Sinai, discusses how neurologic symptoms in individuals with HIV can present in various places in the body while also possibly pointing to a neurologic condition.

Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist, discusses how many unknowns prevail in data concerning neurologic care for LGBTQ+ individuals.

A recent study observed that poor sleep quality and having very little or a lot of sleep were associated with greater likelihood of having had COVID-19 in the past, while poor sleep quality was linked with an increased requirement of hospitalization for severe COVID-19.

Natalia Rost, MD, MPH, FAAN, FAHA, chief of the stroke division at Massachusetts General Hospital and chair of the American Academy of Neurology (AAN) Science Committee, previews the annual meeting and provides a glimpse into what the conference has to offer and its legacy of 75 years.

David Spencer, MD, director of the Comprehensive Epilepsy Center and professor of neurology at Oregon Health and Science University, previews the American Academy of Neurology (AAN) annual meeting for 2023 and says that attendees can expect not only to learn but also to leave feeling humbled and inspired.

A study from the United Kingdom observed that the processes that contribute to obstructive sleep apnea might contribute to early cognitive decline in otherwise healthy individuals.

There are various areas across different patient care and support perspectives that offer opportunities to improve value-based care in oncology, said Ryan Huey, MD, gastrointestinal medical oncologist at MD Anderson Cancer Center in Houston, Texas.

Banner|Aetna's partnership with Virta and their diabetes reversal program brings to light the possibility for expansion to other health issues.

In a value-based cancer care model, patients can more easily access the best quality care and practices can get adequately paid for the services they offer.

Colocating cancer diagnostic services in in community health centers serving historically marginalized populations resulted in reduced time to a diagnosis.

Ryan Huey, MD, gastrointestinal medical oncologist at MD Anderson Cancer Center in Houston, Texas, discussed the vital roles multiple health care providers play in improving outcomes for patients with cancer.

Symptoms of sleep disturbance are associated with an increased risk of stroke and might indicate higher individual risk or be representative of independent risk factors.

Banner|Aetna has partnered with Virta and their diabetes reversal program, which now has data on outcomes and patient populations served so far.

A study conducted in China found that participants who used a smartphone application had improved insomnia severity compared with those who received sleep education.

On this episode of Managed Care Cast, we speak with Virginia Wang, PhD, and Matthew L. Maciejewski, PhD, who talk about their recent study on racial disparities in home dialysis, and what more needs to be done to increase uptake and reduce disparities in home dialysis for non-White patients.

Actionable ways to implement what is known about social determinants of health were discussed among a panel of experts during a webinar broadcast in the beginning of March.

Recognizing markers like atonia index during wakefulness (WAI) that are not present in other hypersomnias might help in the diagnosis of narcolepsy.

A recent study conducted in Norway found that too much or too little self-reported sleep was associated with 44% and 25% greater risk of infection, respectively, and higher antibiotic use.

In a recent webinar, health care experts discussed how addressing social determinants of health by investing in various areas can benefit patients and payers.

A new study examining sleep irregularity and sleep duration found that sleep irregularity was associated with several indictors of heart disease.

The high prevalence of anxiety and depression in patients with narcolepsy suggests that a biological relationship is present between the disorders, but larger studies are needed.